BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20457727)

  • 1. Policy issues and stakeholder concerns regarding the storage and use of residual newborn dried blood samples for research.
    Rothwell E; Anderson R; Botkin J
    Policy Polit Nurs Pract; 2010 Feb; 11(1):5-12. PubMed ID: 20457727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention and research use of residual newborn screening bloodspots.
    Botkin JR; Goldenberg AJ; Rothwell E; Anderson RA; Lewis MH
    Pediatrics; 2013 Jan; 131(1):120-7. PubMed ID: 23209103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing public attitudes on the retention and use of residual newborn screening blood samples: a focus group study.
    Rothwell E; Anderson R; Goldenberg A; Lewis MH; Stark L; Burbank M; Wong B; Botkin JR
    Soc Sci Med; 2012 Apr; 74(8):1305-9. PubMed ID: 22398141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concerns of newborn blood screening advisory committee members regarding storage and use of residual newborn screening blood spots.
    Rothwell EW; Anderson RA; Burbank MJ; Goldenberg AJ; Lewis MH; Stark LA; Wong B; Botkin JR
    Am J Public Health; 2011 Nov; 101(11):2111-6. PubMed ID: 21330580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening.
    Therrell BL; Hannon WH; Bailey DB; Goldman EB; Monaco J; Norgaard-Pedersen B; Terry SF; Johnson A; Howell RR
    Genet Med; 2011 Jul; 13(7):621-4. PubMed ID: 21602691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proxy consent and a national DNA databank: an unethical and discriminatory combination.
    Baumann TK
    Iowa Law Rev; 2001 Jan; 86(2):667-701. PubMed ID: 16184651
    [No Abstract]   [Full Text] [Related]  

  • 7. State laws regarding the retention and use of residual newborn screening blood samples.
    Lewis MH; Goldenberg A; Anderson R; Rothwell E; Botkin J
    Pediatrics; 2011 Apr; 127(4):703-12. PubMed ID: 21444595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of educational materials and destruction/opt-out initiatives for storage and use of residual newborn screening samples.
    Haga SB
    Genet Test Mol Biomarkers; 2010 Oct; 14(5):587-92. PubMed ID: 20858049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public attitudes regarding the use of residual newborn screening specimens for research.
    Botkin JR; Rothwell E; Anderson R; Stark L; Goldenberg A; Lewis M; Burbank M; Wong B
    Pediatrics; 2012 Feb; 129(2):231-8. PubMed ID: 22250018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common criteria among States for storage and use of dried blood spot specimens after newborn screening.
    Petrini C; Olivieri A; Corbetta C; Cerone R; D'Agnolo G; Bompiani A
    Ann Ist Super Sanita; 2012; 48(2):119-21. PubMed ID: 22751553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citizens' values regarding research with stored samples from newborn screening in Canada.
    Bombard Y; Miller FA; Hayeems RZ; Carroll JC; Avard D; Wilson BJ; Little J; Bytautas JP; Allanson J; Axler R; Giguere Y; Chakraborty P
    Pediatrics; 2012 Feb; 129(2):239-47. PubMed ID: 22250019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening residual dried blood spot use for newborn screening quality improvement.
    Benkendorf J; Goodspeed T; Watson MS
    Genet Med; 2010 Dec; 12(12 Suppl):S269-72. PubMed ID: 21150375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Storage and use of residual dried blood spots.
    Webster D; ;
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():49-51. PubMed ID: 15906694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from the residual newborn screening dried blood sample litigation.
    Lewis MH
    J Law Med Ethics; 2015; 43 Suppl 1():32-5. PubMed ID: 25846160
    [No Abstract]   [Full Text] [Related]  

  • 15. Residual newborn screening samples for research: parental information needs for decision-making.
    Rothwell E; Clark L; Anderson R; Botkin JR
    J Spec Pediatr Nurs; 2013 Apr; 18(2):115-22. PubMed ID: 23560583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research use of leftover newborn bloodspots: attitudes of Canadian geneticists regarding storage and informed consent requirements.
    Richer J; Ghebremichael MS; Chudley AE; Robinson WM; Wilfond BS; Solomon MZ
    Genet Med; 2011 Apr; 13(4):305-13. PubMed ID: 20921895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical, legal and social issues in newborn screening in the United States.
    Therrell BL
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():52-8. PubMed ID: 15906695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn dried blood spot screening: residual specimen storage issues.
    Therrell BL; Hannon WH
    Pediatrics; 2012 Feb; 129(2):365-6. PubMed ID: 22250020
    [No Abstract]   [Full Text] [Related]  

  • 19. Storage and use of residual dried blood spots from state newborn screening programs.
    Olney RS; Moore CA; Ojodu JA; Lindegren ML; Hannon WH
    J Pediatr; 2006 May; 148(5):618-22. PubMed ID: 16737872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Assessment of a Shortened Consent Form for the Storage and Research Use of Residual Newborn Screening Blood Spots.
    Rothwell E; Goldenberg A; Johnson E; Riches N; Tarini B; Botkin JR
    J Empir Res Hum Res Ethics; 2017 Dec; 12(5):335-342. PubMed ID: 29073807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.